Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2019-09-07
2019-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heart Rate Variability-guided Training in Cardiac Rehabilitation
NCT04930939
Clinical Value of Heart Rate Variability Indexes to Predict Outcomes After Exercise Training in Chronic Heart Failure
NCT02903225
Intracardiac Hemodynamics and Myocardial Strain in Athletes and First Responders
NCT06075342
Post Myocardial Infarction's Rehabilitation Guided by Heart Rate Variability
NCT03745742
HIIT vs HRV-based Training for Rehabilitation After Stroke
NCT05612776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this line, heart-rate variability (HRV), which focuses on the variability of successive R-R intervals, have gained popularity in monitoring the training status of endurance athletes. This tool enables the detection of fatigue status and assesses the adaptation to training. After high intensity training or a short-term overreached period, there is a decrease in the resting HRV values, reflecting the effect of the fatigue. In addition, the increase of the performance after a training period is related to an increase in resting HRV. This direct fatigue measuring method has been little used to prescribe or regulate exercise prescription. Moreover, this HRV-guided training, also called day-to-day periodization, allows new possibilities for the training load prescription according to an athlete's status, the response to the training load, and the adaptation to training.
On the other hand, regardless HRV-guided training, the athlete performance could also be influenced by precompetitive mood and anxiety, which can also be reflected in the precompetitive HRV scores and the subjective effort perception. This is another interesting line that pretends to be clarified in this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HRV-Group
Athletes will train according to their basal HRV scores. If the resting HRV is higher tan their basal HRV, they will perform a high or moderate intensity training. If the resting HRV is lower, they will perform a low intensity training. If the resting HRV still lower, they will rest. They will not accumulate two or more days of high-moderate intensity training, nor two or more days of rest.
HRV-based training
Intervention based on HRV-guided training for the performance improvement of athletes. Pre-competitive HRV, subjective effort perception, anxiety and mood will also be analysed.
TRAD-Group
Athletes will train according to their trainer plan. Training will not be guided by their basal HRV scores.
TRAD training
Traditional endurance training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HRV-based training
Intervention based on HRV-guided training for the performance improvement of athletes. Pre-competitive HRV, subjective effort perception, anxiety and mood will also be analysed.
TRAD training
Traditional endurance training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Training and running in Spanish Athletics Federation contest during at least two years.
* Stay in the first third of the classification of the previous season last five races.
Exclusion Criteria
* Parameters of blood pressure (BP) outside of normality.
* Respiratory problems diagnosed.
* Be in treatment of psychological problems.
* Regular consumption of drug (s) with direct or indirect effects on the Nervous System (e.g., anxiolytics, antidepressants, neuroleptics).
* Consumption of substances not permitted by the International Athletics Federation (IAF).
* Punctual consumption of medication that could alter the performance due to suffering some disease related to cardiorespiratory system (e.g., influenza).
* Do not attend at least the 90% of the workouts during the intervention.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Almeria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
María Carrasco Poyatos
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alberto González Quílez, Master
Role: STUDY_CHAIR
Universidad de Almeria
Antonio Granero-Gallegos, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad de Almeria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Almería
Almería, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UAL-HRV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.